MBX Biosciences reports positive Phase II data for once-weekly canvuparatide in hypoparathyroidism, highlighting efficacy and safety.
Carsten Pinnow met Professor Zander at “brAIn@NAT25“ and asked him about the promising applications of this new technology.
Autonomous vehicles, connected ecosystems, and smart factories are only the beginning. Generative AI is pushing the auto ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback